Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-126681
Filing Date
2021-04-22
Accepted
2021-04-22 16:06:12
Documents
94
Period of Report
2021-03-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d84467d8ka.htm   iXBRL 8-K/A 376723
2 EX-23.1 d84467dex231.htm EX-23.1 3315
3 EX-23.2 d84467dex232.htm EX-23.2 2938
4 EX-99.1 d84467dex991.htm EX-99.1 532571
5 EX-99.2 d84467dex992.htm   iXBRL EX-99.2 1486523
6 EX-99.3 d84467dex993.htm EX-99.3 214085
  Complete submission text file 0001193125-21-126681.txt   13191089

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20210305.xsd EX-101.SCH 113754
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibrx-20210305_cal.xml EX-101.CAL 86813
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibrx-20210305_def.xml EX-101.DEF 488471
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20210305_lab.xml EX-101.LAB 890368
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20210305_pre.xml EX-101.PRE 696842
12 EXTRACTED XBRL INSTANCE DOCUMENT d84467d8ka_htm.xml XML 2326360
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37507 | Film No.: 21844824
SIC: 2836 Biological Products, (No Diagnostic Substances)